Effect of a plant stanol ester-containing spread, placebo spread, or Mediterranean diet on estimated cardiovascular risk and lipid, inflammatory and haemostatic factors

Nutrition, Metabolism and Cardiovascular Diseases

Volumn 21, Issue 3, 2011, Pages 213-221

  Athyros, V G ^a   Kakafika, A I ^a   Papageorgiou, A A ^a   Tziomalos, K ^b   Peletidou, A ^c   Vosikis, C ^c   Karagiannis, A ^a   Mikhailidis, D P ^b  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^b ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^c Aristotle University of Thessaloniki   (Greece)

Author keywords

Cardiovascular risk; Hypercholesterolaemia; Mediterranean diet; Plant stanol ester; Primary prevention

Indexed keywords

AUTACOID; C REACTIVE PROTEIN; CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; SITOSTEROL DERIVATIVE; STANOL ESTER; TRIACYLGLYCEROL;

ARTICLE; BLOOD; BLOOD PRESSURE; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; COMPARATIVE STUDY; CONDIMENT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET THERAPY; HOSPITALIZATION; HUMAN; HYPERCHOLESTEROLEMIA; MALE; MEDITERRANEAN DIET; MIDDLE AGED; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; TIME;

BLOOD PRESSURE; C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; CHOLESTEROL; CHOLESTEROL, LDL; CONDIMENTS; DIET, MEDITERRANEAN; HUMANS; HYPERCHOLESTEROLEMIA; INFLAMMATION MEDIATORS; MALE; MIDDLE AGED; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SITOSTEROLS; TIME FACTORS; TRIGLYCERIDES;

EID: 79951508815     PISSN: 09394753     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.numecd.2009.08.014     Document Type: Article

References (50)

1. Martínez-González M.A., de la Fuente-Arrillaga C., Nunez-Cordoba J.M., Basterra-Gortari F.J., Beunza J.J., Vazquez Z., et al. Adherence to Mediterranean diet and risk of developing diabetes: prospective cohort study. BMJ 2008, 14(336):1348-1351.
2. Trichopoulou A., Critselis C. Mediterranean diet and longevity. Eur J Cancer Prev 2004, 13:453-456.
3. Knoops K.T., de Groot L.C., Kromhout D., Perrin A.E., Moreiras-Varela O., Menotti A., et al. Mediterranean diet, lifestyle factors, and 10-year mortality in elderly European men and women: the HALE project. J Am Med Assoc 2004, 292:1433-1439.
4. Willet W.C. The Mediterranean diet: science and practice. Public Health Nutr 2006, 9:105-110.
5. Mitrou P.N., Kipnis V., Thiébaut A.C., Reedy J., Subar A.F., Wirfält E., et al. Mediterranean dietary pattern and prediction of all-cause mortality in a US population: results from the NIH-AARP Diet and Health Study. Arch Intern Med 2007, 167:2461-2468.
6. Rodrigues S.S., Caraher M., Trichopoulou A., de Almeida M.D. Portuguese households' diet quality (adherence to Mediterranean food pattern and compliance with WHO population dietary goals): trends, regional disparities and socioeconomic determinants. Eur J Clin Nutr 2008, 62:1263-1272.
7. Sofi F., Innocenti G., Dini C., Masi L., Battistini N.C., Brandi M.L., et al. Low adherence of a clinically healthy Italian population to nutritional recommendations for primary prevention of chronic diseases. Nutr Metab Cardiovasc Dis 2006, 16:436-444.
8. Correa Leite M.L., Nicolosi A., Cristina S., Hauser W.A., Pugliese P., Nappi G. Dietary and nutritional patterns in an elderly rural population in Northern and Southern Italy: (I). A cluster analysis of food consumption. Eur J Clin Nutr 2003, 57:1514-1521.
9. Sofi F., Vecchio S., Giuliani G., Martinelli F., Marcucci R., Gori A.M., et al. Dietary habits, lifestyle and cardiovascular risk factors in a clinically healthy Italian population: the "Florence" diet is not Mediterranean. Eur J Clin Nutr 2005, 58:584-591.
10. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults Executive Summary of the Third Report of National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). J Am Med Assoc 2001, 285:2486-2497.
11. Grundy S.M. Stanol esters as a component of maximal dietary therapy in the national cholesterol education program adult treatment Panel III Report. Am J Cardiol 2005, 96(Suppl. 1):47-50.
12. Plat J., Mensink R.P. Increased intestinal ABC A1 expression contributes to the decrease in cholesterol absorption after plant stanol consumption. FASEB J 2002, 16:1248-1253.
13. Escurriol V., Cofán M., Serra M., Bulló M., Basora J., Salas-Salvadó J., et al. Serum sterol responses to increasing plant sterol intake from natural foods in the Mediterranean diet. Eur J Nutr 2009 May 3, [Epub ahead of print].
14. Trichopoulou A., Kouris-Blazos A., Wahlqvist M.L., Gnardellis C., Lagiou P., Polychronopulos E., et al. Diet and overall survival in the elderly. BMJ 1995, 311:1457-1460.
15. Trichopoulou A., Costacou T., Bamia C., Trichopoulos D. Adherence to a Mediterranean diet and survival in a Greek population. N Engl J Med 2003, 348:2599-2608.
16. Panagiotakos D.B., Pitsavos C., Arvaniti F., Stefanadis C. Adherence to the Mediterranean food pattern predicts the prevalence of hypertension, hypercholesterolemia, diabetes and obesity, among healthy adults; the accuracy of the MedDietScore. Prev Med 2007, 44:335-340.
17. Plat J., Mensink R.P. Effects of diets enriched with two different plant stanol ester mixtures on plasma Ubiquinol-10 and fat-soluble antioxidant concentrations. Metabolism 2001, 50:520-529.
18. Keys A., Menotti A., Karvonen M.J., Aravanis C., Blackburn H., Buzina R., et al. The diet and 15-year death rate in the Seven Countries Study. Am J Epidemiol 1986, 124:903-915.
19. De Lorgeril M., Salen P., Martin J.L., Monjaud I., Delaye J., Mamelle N. Mediterranean diet, traditional risk factors and the rate of cardiovascular complications after myocardial infarction: final report of the Lyon Diet Heart Study. Circulation 1999, 99:779-785.
20. Kafatos A., Diacatou A., Voukiklaris G., Nikolakakis N., Vlachonikolis J., Kounali D., et al. Heart disease risk-factor status and dietary changes in the Cretan population over the past 30 years: the Seven Countries Study. Am J Clin Nutr 1997, 65:1882-1886.
21. Barradas M.A., Christofides J.A., Jeremy J.Y., Mikhailidis D.P., Fry D.E., Dandona P. The effect of olive oil supplementation on human platelet function, serum cholesterol-related variables and plasma fibrinogen concentrations: a pilot study. Nutr Res 1990, 10:403-411.
22. Chrysohoou C., Panagiotakos D.B., Pitsavos C., Das U.N., Stefanadis C. Adherence to the Mediterranean diet attenuates inflammation and coagulation process in healthy adults. The Attica study. J Am Coll Cardiol 2004, 44:152-158.
23. Weststrate J.A., Meijer G.W. Plant sterol-enriched margarines and reduction of plasma total- and LDL-cholesterol concentrations in normocholesterorolaemic and mildly hypercholesterolaemic subjects. Eur J Clin Nutr 1998, 52:334-343.
24. Nguyen T.T., Dale L.C., von Bergmann K., Croghan I.T. Cholesterol-lowering effect of stanol ester in a US population of mildly hypercholesterolemic men and women: a randomized controlled trial. Mayo Clin Proc 1999, 74:1198-1206.
25. Hendriks H.F., Weststrate J.A., van Vliet T., Meijer G.W. Spreads enriched with three different levels of vegetable oil sterols and the degree of cholesterol lowering in normocholesterolaemic and mildly hypercholesterolaemic subjects. Eur J Clin Nutr 1999, 53:319-327.
26. Hallikainen M.A., Sarkkinen E.S., Gylling H., Erkkilä A.T., Uusitupa M.I. Comparison of the effects of plant sterol ester and plant stanol ester-enriched margarines in lowering serum cholesterol concentrations in hypercholesterolaemic subjects on a low-fat diet. Eur J Clin Nutr 2000, 54:715-725.
27. Plat J., van Onselen E.N., van Heugten M.M., Mensink R.P. Effects on serum lipids, lipoproteins and fat soluble antioxidant concentrations of consumption frequency of margarines and shortenings enriched with plant stanol esters. Eur J Clin Nutr 2000, 54:671-677.
28. Law M.R. Plant sterol and stanol margarines and health. BMJ 2000, 320:861-864.
29. Panagiotakos D.B., Pitsavos C., Chrysohoou C., Skoumas I., Stefanadis C. ATTICA Study. Five-year incidence of cardiovascular disease and its predictors in Greece: the ATTICA study. Vasc Med 2008, 13:113-121.
30. Cater N.B., Garcia-Garcia A.B., Vega G.L., Grundy S.M. Responsiveness of plasma lipids and lipoproteins to plant stanol esters. Am J Cardiol 2005, 96(1A):23D-28D.
31. De Jong A., Plat J., Bast A., Godschalk R.W., Basu S., Mensink R.P. Effects of plant sterol and stanol ester consumption on lipid metabolism, antioxidant status and markers of oxidative stress, endothelial function and low-grade inflammation in patients on current statin treatment. Eur J Clin Nutr 2008, 62:263-273.
32. Ridker P.M., Rifai N., Clearfield M., Downs J.R., Weis S.E., Miles J.S., et al. Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events. N Engl J Med 2001, 344:1959-1965.
33. Ridker P.M., Danielson E., Fonseca F.A., Genest J., Gotto A.M., Kastelein J.J., et al. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med 2008, 359:2195-2207.
34. Ridker P.M., Cannon C.P., Morrow D., Rifai N., Rose L.M., McCabe C.H., et al. C-reactive protein levels and outcomes after statin therapy. N Engl J Med 2005, 352:20-28.
35. Tziomalos K., Athyros V.G., Karagiannis A., Mikhailidis D.P. JUPITER: major implications for vascular risk assessment. Curr Med Res Opin 2009, 25:133-137.
36. Ridker P.M., Danielson E., Fonseca F.A., Genest J., Gotto A.M., Kastelein J.J., et al. Reduction in C-reactive protein and LDL cholesterol and cardiovascular event rates after initiation of rosuvastatin: a prospective study of the JUPITER trial. Lancet 2009, 373:1175-1182.
37. Plat J., Mensink R.P. Vegetable oil based versus wood based stanol ester mixtures: effects on serum lipids and hemostatic factors in non-hypercholesterolemic subjects. Atherosclerosis 2000, 148:101-112.
38. Salen G., Shefer S., Nguyen L., Ness G.C., Tint G.S., Shore V. Sitosterolemia. J Lipid Res 1992, 33:945-955.
39. Glueck C.J., Speirs J., Tracy T., Streicher P., Illig E., Vandegrift J. Relationships of serum plant sterols (phytosterols) and cholesterol in 595 hypercholesterolemic subjects, and familial aggregation of phytosterols, cholesterol, and premature coronary heart disease in hyperphytosterolemic probands and their first-degree relatives. Metabolism 1991, 40:842-848.
40. Wilund K.R., Yu L., Xu F., Vega G.L., Grundy S.M., Cohen J.C., et al. No association between plasma levels of plant sterols and atherosclerosis in mice and men. Arterioscler Thromb Vasc Biol 2004, 24:2326-2332.
41. Plat J., Beugels I., Gijbels M.J.J., de Winther M.P.J., Mensink R.P. Plant sterol or stanol esters retard lesion formation in LDL receptor-deficient mice independent of changes in serum plant sterols. J Lipid Res 2006, 47:2762-2771.
42. Fassbender K., Lütjohann D., Dik M.G., Bremmer M., König J., Walter S., et al. Moderately elevated plant sterol levels are associated with reduced cardiovascular risk-The LASA study. Atherosclerosis 2008, 196:283-288.
43. Sudhop T., Gottwald B.M., von Bergmann K. Serum plant sterols as a potential risk factor for coronary heart disease. Metabolism 2002, 51:1519-1521.
44. Assmann G., Paul Cullen P., Erbey J., Rameyd D.R., Kannenberga F., Schulte H. Plasma sitosterol elevations are associated with an increased incidence of coronary events in men: results of a nested case-control analysis of the Prospective Cardiovascular Münster (PROCAM) study. Nutr Metab Cardiovasc Dis 2006, 16:13-21.
45. Rajaratnam R.A., Gylling H., Miettinen T.A. Independent association of serum squalene and noncholesterol sterols with coronary artery disease in postmenopausal women. J Am Coll Cardiol 2000, 35:1185-1191.
46. Miettinen T.A., Gylling H., Strandberg T., Sarna S., for the Finnish 4S Investigators Baseline serum cholestanol as predictor of recurrent coronary events in subgroup of Scandinavian Simvastatin Survival Study (4S). Br Med J 1998, 316:1127-1130.
47. Miettinen T.A., Strandberg T.E., Gylling H., for the Finnish Investigators of the Scandinavian Simvastatin Survival Study Group Non-cholesterol sterols and cholesterol lowering by long-term simvastatin treatment in coronary patients: relation to basal serum cholestanol. Arterioscler Thromb Vasc Biol 2000, 20:1340-1346.
48. Miettinen T.A., Railo M., Lepäntalo M., Gylling H. Plant sterols in serum and in atherosclerotic plaques of patients undergoing carotid endarterectomy. J Am Coll Cardiol 2005, 45:1794-1801.
49. Salen G., von Bergmann K., Lütjohann D., Kwiterovich P., Kane J., Patel S.B., the Multicenter Sitosterolemia Study Group, et al. Ezetimibe effectively reduces plasma plant sterols in patients with sitosterolemia. Circulation 2004, 109:966-971.
50. Salen G., Starc T., Sisk C.M., Patel S.B. Intestinal cholesterol absorption inhibitor ezetimibe added to cholestyramine for sitosterolemia and xanthomatosis. Gastroenterology 2006, 130:1853-1857.